Product analysis
Hawthorn Extract 300 mg offers an inexpensive, focused herbal option. Its preparation does not establish the same heart-related effects as the particular extracts behind the limited findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The hawthorn extract has a named marker, while its comparative quality remains uncertain. The description does not establish a match to a particular preparation behind the heart findings.
Ingredient Transparency100
The extract description and an amount are provided, helping basic comparison. Differing quantity declarations cannot be combined into a confirmed total.
Value For Money100
The labeled serving cost is favorable. Differing amount declarations limit any closer comparison based on extract quantity.
Customer Satisfaction85
Customer ratings are very positive across a large body of feedback. They describe satisfaction rather than establishing health benefits.
Product Focus73
The single-herb approach keeps the heart-related purpose focused. Benefits from specific clinical extracts cannot be assumed to transfer to this preparation.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.04
- Also available
Extra Strength Hawthorn Extract 600 mg$16.20- Customer rating
- 4.7 · 2,108 ratings
Goals
Hawthorn has been studied mainly as specific standardized extracts in clinical heart failure, with conflicting findings. Those results do not establish benefit for this ordinary hawthorn preparation or routine cardiovascular prevention. Its declared amount was recognized in the saved findings, but amount alone cannot resolve the difference in preparation and population.
How this product is rated for Heart Health
Ingredient fit91
Goal fit
Dose adequacy
Pathways18
Depth
Breadth
Evidence66
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Hawthorn’s cardiovascular research mainly concerns specific extracts used in treated heart failure. A large trial did not improve its primary cardiac-event outcome, and generic hawthorn cannot inherit the tested extract’s findings. The declared amount therefore does not establish routine cardiovascular benefit or identify the studied preparation.
How this product is rated for Cardiovascular Support
Ingredient fit91
Goal fit
Dose adequacy
Pathways49
Depth
Breadth
Evidence81
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn extract (Vitexin-2”-O-Rhamnoside) | 300 mg | |
Hawthorn Berry | 200 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.